BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20799950)

  • 1. L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions.
    Pfeifer M; Schirmer U; Geismann C; Schäfer H; Sebens S; Altevogt P
    BMC Mol Biol; 2010 Aug; 11():64. PubMed ID: 20799950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the transcription factor Slug to the L1CAM promoter is essential for transforming growth factor-β1 (TGF-β)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cells.
    Geismann C; Arlt A; Bauer I; Pfeifer M; Schirmer U; Altevogt P; Müerköster SS; Schäfer H
    Int J Oncol; 2011 Jan; 38(1):257-66. PubMed ID: 21109948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma.
    Schirmer U; Doberstein K; Rupp AK; Bretz NP; Wuttig D; Kiefel H; Breunig C; Fiegl H; Müller-Holzner E; Zeillinger R; Schuster E; Zeimet AG; Sültmann H; Altevogt P
    Oncotarget; 2014 Jan; 5(2):462-72. PubMed ID: 24497324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slug-dependent upregulation of L1CAM is responsible for the increased invasion potential of pancreatic cancer cells following long-term 5-FU treatment.
    Lund K; Dembinski JL; Solberg N; Urbanucci A; Mills IG; Krauss S
    PLoS One; 2015; 10(4):e0123684. PubMed ID: 25860483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas.
    Huszar M; Pfeifer M; Schirmer U; Kiefel H; Konecny GE; Ben-Arie A; Edler L; Münch M; Müller-Holzner E; Jerabek-Klestil S; Abdel-Azim S; Marth C; Zeimet AG; Altevogt P; Fogel M
    J Pathol; 2010 Apr; 220(5):551-61. PubMed ID: 20077528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens.
    Schirmer U; Fiegl H; Pfeifer M; Zeimet AG; Müller-Holzner E; Bode PK; Tischler V; Altevogt P
    BMC Cancer; 2013 Mar; 13():156. PubMed ID: 23530769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperation of Sox4 with β-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma.
    Inoue H; Takahashi H; Hashimura M; Eshima K; Akiya M; Matsumoto T; Saegusa M
    BMC Cancer; 2016 Feb; 16():53. PubMed ID: 26841870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-193a-3p inhibition of the Slug activator PAK4 suppresses non-small cell lung cancer aggressiveness via the p53/Slug/L1CAM pathway.
    Liu X; Min S; Wu N; Liu H; Wang T; Li W; Shen Y; Zhao C; Wang H; Qian Z; Xu H; Chen Y; Wang X
    Cancer Lett; 2019 Apr; 447():56-65. PubMed ID: 30685413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of L1CAM expression in addition to ProMisE in endometrial cancer.
    Kim J; Kim SI; Kim NR; Kim H; Kim HS; Chung HH; Kim JW; Lee C; Lee M
    Gynecol Oncol; 2023 Jul; 174():231-238. PubMed ID: 37236032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L1CAM is expressed in triple-negative breast cancers and is inversely correlated with androgen receptor.
    Doberstein K; Milde-Langosch K; Bretz NP; Schirmer U; Harari A; Witzel I; Ben-Arie A; Hubalek M; Müller-Holzner E; Reinold S; Zeimet AG; Altevogt P; Fogel M
    BMC Cancer; 2014 Dec; 14():958. PubMed ID: 25510351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer.
    Tischler V; Pfeifer M; Hausladen S; Schirmer U; Bonde AK; Kristiansen G; Sos ML; Weder W; Moch H; Altevogt P; Soltermann A
    Mol Cancer; 2011 Oct; 10():127. PubMed ID: 21985405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of β-Catenin and L1CAM Expressions in Type I Endometrial Carcinoma.
    Manule Y; Miskad UA; Masadah R; Nelwan B; Cangara MH; Mardiati M
    Asian Pac J Cancer Prev; 2023 Apr; 24(4):1413-1417. PubMed ID: 37116166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA hypomethylation at the CpG island is involved in aberrant expression of the L1 cell adhesion molecule gene in colorectal cancer.
    Kato K; Maesawa C; Itabashi T; Fujisawa K; Otsuka K; Kanno S; Tada H; Tatemichi Y; Kotani K; Oikawa H; Sugai T; Wakabayashi G; Masuda T
    Int J Oncol; 2009 Sep; 35(3):467-76. PubMed ID: 19639167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β1-dependent L1CAM expression has an essential role in macrophage-induced apoptosis resistance and cell migration of human intestinal epithelial cells.
    Schäfer H; Struck B; Feldmann EM; Bergmann F; Grage-Griebenow E; Geismann C; Ehlers S; Altevogt P; Sebens S
    Oncogene; 2013 Jan; 32(2):180-9. PubMed ID: 22349829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
    Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A
    Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts.
    Lambertini E; Franceschetti T; Torreggiani E; Penolazzi L; Pastore A; Pelucchi S; Gambari R; Piva R
    BMC Mol Biol; 2010 Feb; 11():13. PubMed ID: 20128911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linking L1CAM-mediated signaling to NF-κB activation.
    Kiefel H; Pfeifer M; Bondong S; Hazin J; Altevogt P
    Trends Mol Med; 2011 Apr; 17(4):178-87. PubMed ID: 21195665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.
    Gavert N; Shvab A; Sheffer M; Ben-Shmuel A; Haase G; Bakos E; Domany E; Ben-Ze'ev A
    Cancer Res; 2013 Sep; 73(18):5754-63. PubMed ID: 24008320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.
    Geismann C; Morscheck M; Koch D; Bergmann F; Ungefroren H; Arlt A; Tsao MS; Bachem MG; Altevogt P; Sipos B; Fölsch UR; Schäfer H; Müerköster SS
    Cancer Res; 2009 May; 69(10):4517-26. PubMed ID: 19435915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial cancer prognosis correlates with the expression of L1CAM and miR34a biomarkers.
    Corrado G; Laquintana V; Loria R; Carosi M; de Salvo L; Sperduti I; Zampa A; Cicchillitti L; Piaggio G; Cutillo G; Falcioni R; Vizza E
    J Exp Clin Cancer Res; 2018 Jul; 37(1):139. PubMed ID: 29980240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.